Quarterly report [Sections 13 or 15(d)]

SCHEDULE OF STOCK OPTIONS ACTIVITY (Details)

v3.25.4
SCHEDULE OF STOCK OPTIONS ACTIVITY (Details)
6 Months Ended
Dec. 31, 2025
USD ($)
$ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Equity [Abstract]    
Number of Shares, Outstanding, beginning balance | shares 796,660 1,605,060
Weighted Average Exercise Price, Outstanding, beginning balance $ 4.10 $ 4.85
Number of Shares, Granted | shares 536,239
Weighted Average Exercise Price, Granted $ 1.88
Weighted Average Grant Date Fair Value, Granted $ 1.23
Number of Shares, Exercised | shares (62,125)
Weighted Average Exercise Price, Exercised $ 4.10
Aggregate intrinsic Value, Exercised | $ $ 115,000
Number of Shares, Forfeited and cancelled | shares (193,167) (111,782)
Weighted Average Exercise Price, Forfeited and cancelled $ 3.89 $ 3.39
Number of Shares, Outstanding, ending balance | shares 1,077,607 1,493,278
Weighted Average Exercise Price, Outstanding, ending balance $ 3.03 $ 4.96
Weighted Average Remaining Contract Term (# years), Outstanding 8 years 18 days 7 years 4 months 17 days
Aggregate intrinsic Value, Outstanding | $
Number of Shares, Exercisable, ending balance | shares 424,574 757,220
Weighted Average Exercise Price, Exercisable, ending balance $ 4.01 $ 6.39
Weighted Average Remaining Contract Term (# years), exercisable 6 years 6 months 21 days 6 years 2 months 12 days
Aggregate intrinsic Value, Exercisable | $